Recent Secular Trends in Pubertal Timing: Implications For Evaluation and Diagnosis of Precocious Puberty
Recent Secular Trends in Pubertal Timing: Implications For Evaluation and Diagnosis of Precocious Puberty
Recent Secular Trends in Pubertal Timing: Implications For Evaluation and Diagnosis of Precocious Puberty
Key Words translated into revision of age limits for evaluation of PP due
Precocious puberty ⴢ Pubertal timing ⴢ Pubertal to the risk of misdiagnosing rapid progressive PP as well as
examination ⴢ Orchidometry ⴢ Thelarche intracranial and other underlying pathology.
Copyright © 2012 S. Karger AG, Basel
Abstract
The decline in age at puberty in the general population has Introduction
been paralleled by an increase in the number of girls referred
for evaluation of precocious puberty (PP). In 1999, The Law- Puberty is an important developmental milestone. It
son Wilkins Pediatric Endocrine Society recommended a can be considered as a complex sequence of biological
lowering of the age limit for evaluation of PP in girls. How- events leading to progressive maturation of sexual char-
ever, the limited evidence on which these recommendations acteristics ultimately leading to attainment of full repro-
were based led many experts to question these new sugges- ductive capacity. The timing of puberty has received con-
tions. The emergence of new European pubertal timing data siderable attention during the past decades due to the as-
evaluated by robust clinical as well as biochemical markers sociations with risk of breast cancer and cardiovascular
has broadened our insight on how to interpret the recent disease in adulthood [1].
pubertal changes. The recent pubertal trends have resulted Until the mid-20th century, a gradual decline in age at
in a concomitant lowering of the lower limit of normality of menarche has been reported in most industrialized pop-
the pubertal onset. However, evidence suggests that age at ulations [2]. Thereafter, this trend ceased as a result
the gonadotropin and sex steroid surges have not changed. of increased stability in socioeconomic conditions, im-
Thus, it looks as if an increasing proportion of contemporary proved nutrition and hygiene. In the 1990s, two Ameri-
early pubertal girls may experience isolated gonadotropin- can studies turned our attention towards new secular pu-
independent thelarche rather than central PP, which may not bertal trend in both girls and boys [3–7]. Although data
be discernible on pubertal examination alone. Thus, the from European populations collected in the same period
population-based limits of normality should not be directly failed to show similar trends [8, 9], contemporary studies
Age at menarche
Denmark
13.5
(years)
17 Portugal
13.0
11.5 US 12.5
In contrast to menarche, age at onset of breast develop- years, 6.7% of white girls and 27.2% of African-American
ment seems to have declined markedly during the last girls in the PROS study [3] fulfilled the criteria for evalu-
two decades (fig. 2). Before the 1980s, the mean age at on- ation of PP with either breast or pubic hair development.
set of breast development was consistently reported to be These findings prompted The Lawson Wilkins Pediatric
approximately 11 years in both American and European Endocrine Society (LWPES) to re-examine the age limit
studies [32]. However, data from the American popula- for evaluation of PP in the US and recommended that
tion-based Third National Health and Nutrition Exami- evaluation should only be undertaken if clinical signs of
nation Survey (NHANES III) conducted from 1988 to puberty were present before the age of 7 years in white
1994 showed mean ages at onset of puberty in girls well girls and before the age of 6 years in African-American
below 10 years [6]. Although most marked changes were girls [14]. Many pediatric endocrinologists have subse-
observed in non-Hispanic black girls, low ages at onset of quently questioned the evidence on which these recom-
breast development were reported in all ethnic groups. mendations were based and argued that the PROS study
However, data reliability in the NHANES III was criti- was not representative for the general American popula-
cized due to reliance on visual grading of breast stages tion [17, 18]. In addition, it only included girls up to the
alone. Nevertheless, a contemporary large-scale Ameri- age of 12 years, and may therefore have missed the late
can study, the Pediatric Research in Office Settings pubertal girls potentially leading to a slight underestima-
(PROS) study, included breast palpation in 39% of the ex- tion of the true age at pubertal onset. However, based on
aminations and confirmed the NHANES III findings the newest US data by Biro et al. [39], the proportion of
with even marginally lower mean ages at onset of breast white and black girls presenting with breast development
development [3]. Using the classical diagnostic limit of 8 before the age of 8 years seems to be increasing further
0.6
may now be evident in Europe with a 15 years’ delay. At
present, the figures from Europe are not as drastic as
0.4
those seen in the US, although the most recent studies
2006–08
0.2
1991–93 indicate that approximately 5% of white girls have onset
0 of breast development before 8 years of age [11, 10, 40].
a 6 8 10 12 14 16 As for onset of later pubertal stages, a secular trend
1.0 analysis between HNANES III and the previous popula-
Probability of menarche
18 6
LH (IU/l)
LH (IU/l)
12 4
6 2
0 0
6 8 10 12 14 16 18 20 6 8 10 12 14 16 18 20
2.0 50
2006–08 2006–08
1991–93 1991–93
Fig. 4. Reproductive hormone levels ac- 1.6 40
Testosterone (nmol/l)
cording to chronological age in 1,276
Estradiol (μmol/l)
Number of girls
60
opened a lively debate among pediatric endocrinologist
50
concerning the necessity of a revision of the age limit for
40
what is considered pubertal precocity requiring further
30
diagnostic evaluation. Although the great majority of re-
20
cent data consistently indicate that age at pubertal onset 10
is becoming earlier in both Europe [10, 11] and the US [3, 0
6], extrapolation from these population-based findings to 1993 1995 1997 1999 2001 2003 2005 2007
redefine the age limit for evaluation of PP may not be ap- Year of referral
propriate. If the recent secular trends in puberty are driv-
en primarily by an increase in isolated gonadotropin-in-
Fig. 5. Number of girls per year diagnosed with early normal pu-
dependent thelarche, lowering of the age limit for evalu- berty (ENV), premature adrenarche (PA), premature thelarche
ation of PP will overlook some girls with true rapid (PT), and idiopathic CPP (ICPP) according to year of referral
progressive PP from the age of 6 or 7 years leading, if un- (1993–2008) in a single tertiary pediatric endocrine center. Repro-
treated, to menarche by age 8 or 9, which by population- duced with permission [13].
based standards will be 1–2 years below the 3rd percentile
for normal-timed menarche in both black and white girls.
Another point of concern for a lowering of the age lim-
it for evaluation of PP in girls addressed by many pediat- limit for referral based solely on trends in age at breast
ric endocrinologists is the possible misdiagnosis of po- development in the general population.
tentially treatable underlying pathology. In the wake
of the LWPES recommendations, several independent
groups have undertaken retrospective evaluations of pa- Conclusion
thology in girls with CPP with pubertal onset after the
age of 6 years. The general conclusion from these studies The trend towards earlier mean age at onset of breast
is that implementation of the LWPES recommendations development in girls is accompanied by a downward shift
will lead to misdiagnosis of CNS abnormalities in 2–30% in the entire age distribution at pubertal onset, resulting
of the girls, some of whom needing surgery and chemo- in a concomitant lowering of the lower limit of normality
therapy [15, 53, 58, 59]. In addition to intracranial pathol- of breast development. However, these findings are based
ogy, Midyett et al. [16] reported that 12% of the girls eval- on population-based studies of healthy girls who did not
uated for PP with pubertal onset after the age show associated secular trends in timing of the pubertal
of 6 years manifested pathologic endocrine conditions. LH and estradiol surges. Thus, it appears as if we may
However, two thirds of these patients presented with hy- primarily be witnessing a phenomenon of isolated gonad-
perinsulinemia that, although girls with CPP may have otropin-independent thelarche among our contempo-
an increased risk of insulin resistance [60], could be a rary girls. It remains to be seen whether or not this ear-
normal finding considering the high obesity prevalence lier breast development will advance the entire sequence
(45%) in that cohort. Thus, 5–10% of girls with CPP may of sexual maturation processes, and if it will have possible
be misdiagnosed if the age limit for evaluation is lowered long-term side effects in the majority of early maturing
according to the LWPES recommendations. girls, or only in the small subset of those with rapid pro-
Altogether, the cutoff values for ages at which diagnos- gressive pubertal development leading to early menarche.
tic evaluation is needed should not be lowered at present, Due to the risk of overlooking rapid progressive PP as well
as this would result in a failure to identify children with as the risk of misdiagnosing intracranial and other un-
rapid progressive PP as well as failure to detect underly- derlying pathology, we do not believe that the population-
ing pathology that would respond to early intervention. based limits of normality should be translated into revi-
The criteria for evaluation of PP should rely on addition- sion of age limits at which girls with PP should be referred
al evaluation of pubertal progression, skeletal maturation for diagnostic workup including brain MRI.
or growth tempo, rather than simply lowering the age